What is BNT162b2 - a Covid-19 Vaccine of Pfizer and BioNTech
A vaccine named BNT162b2 jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials. What to Know? Facts about Covid-19 Vaccine named BNT162b2?